C07D 239/16
Acylated on said nitrogen atoms
Official title: acylated on said nitrogen atoms
C07D239/16 (Acylated on said nitrogen atoms) appears on 26 US grants and 17 published applications in this corpus.
Search patents in C07D- Granted patents
- 26
- Published applications
- 17
- Assignees
- 25
- Inventors
- 65
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 1 |
| 2003 | 1 | 1 |
| 2004 | 1 | 3 |
| 2005 | 2 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 2 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 3 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 2 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing uracil compound1 Sep 2026US 12,723,032 B2Nippon Soda Co., Ltd.
- Aryl-n-aryl derivatives for treating a RNA virus infection23 Sep 2025US 12,421,206 B2Abivax
- Aryl-n-aryl derivatives for treating a RNA virus infection11 Mar 2025US 12,247,018 B2Abivax
- Aryl-n-aryl derivatives for treating a RNA virus infection29 Aug 2023US 11,739,073 B2Abivax
- Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists3 Mar 2020US 10,577,330 B2Saint Louis University
- Method for producing uracil compound26 Sep 2024US 2024/0317692 A1Nippon Soda Co., Ltd.
- Aryl-n-aryl derivatives for treating a rna virus infection10 Nov 2022US 2022/0356175 A1Abivax
- Small molecules targeting mutant mammalian proteins2 Dec 2021US 2021/0371403 A1Jnana Therapeutics Inc.
- Aryl-n-aryl derivatives for treating a rna virus infection30 Sep 2021US 2021/0300871 A1Abivax
- Aryl-n-aryl derivatives for treating a rna virus infection29 Apr 2021US 2021/0122732 A1Abivax
Most cited
By later US patents
- Guanidine derivatives as inhibitors of cell adhesion31US 6,340,679 B12002
- Nitro- or cyano-derivatives of 2-imino-imidazolines and 2-imino-tetrahydropyrimidines20US 4,880,933 ANihon Tokushu Noyaku Seizo K. K. · 1989
- Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion14US 6,313,119 B1Adventis Pharma Deutschland GmbH · 2001
- 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives8US 4,261,995 ASyntex (U.S.A.) Inc. · 1981
- Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists7US 6,492,356 B1Aventis Pharma Deutschland GmbH · 2002